By Henrik Bo Larsen, ICDK Director of Business Development
One of the unstated facts of medicine is that we don’t always understand the relationship between treatments and outcomes. For example, the U.S. spends over $2.6 trillion on health care every year, including over $600 billion in unexplained variations in treatments: in other words treatments that cause no differences in outcomes. This is where big data analytics, coupled with the right educational interventions, can make a huge difference to healthcare outcomes.
….was exactly what the department of Health and Care from the municipality of Aarhus was doing when they visited the Valley last month. Like in every other western country it is not uncommon for Danes to live well into their 80ties or 90ties, whereby the healthcare system is experiencing rising challenges in regards of providing care for the increasing aging population. With a special focus on eldercare in the US, the use of new technologies, and the ensuring of a dignified old age, the municipality of Aarhus went over here to seek inspiration and challenge how things are done in Aarhus, while at the same time share knowledge and experience with relevant parties and potential partners..
The Danish Consulate General hosted an Executive Roundtable on ‘Drug Development in Denmark’ at the BIO convention in Chicago to promote the Danish biotechnology cluster as an area of business excellence of Denmark. Danish representatives of Novo Nordisk, AbbVie and Eli Lilly presented case studies to the key stakeholders of the industry.